4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0000899243-15-009490
CEO & Chief Science Officer sold 68,117 shares at an average $14.71 ($1,001,909)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & Chief Science Officer | 2015-12-04 | Sale | −28,712 | $14.95 | $429,302 | 7,564,299 | I |
| Zhang Jack Y. CEO & Chief Science Officer | 2015-12-07 | Sale | −15,046 | $14.59 | $219,490 | 7,549,253 | I |
| Zhang Jack Y. CEO & Chief Science Officer | 2015-12-08 | Sale | −24,359 | $14.50 | $353,118 | 7,524,894 | I |
| Open-market sales · 68,117 sh · avg $14.71 · $1,001,909 | |||||||
Loading xslF345X03/doc4.xml…